ANN ARBOR — Ann Arbor-based Adeona Pharmaceuticals Inc. (NYSE Amex: AEN) said Thursday that it had received shareholder approval to change its corporate name to Synthetic Biologics Inc.

Synthetic Biologics is a pharmaceutical company developing therapeutics and medicines based on synthetic DNA. Company officials said the new name more accurately reflects the company’s business.

READ MORE: GM, Toyota, Target, and Others Say They Will Still Enforce Mask-Wearing In Texas

Company officials said it’s expected that the company’s shares will start trading under its new name and stock ticker symbol, “SYN,” on Thursday.

READ MORE: Volvo Announces All-Electric Lineup by 2030

Synthetic Biologics’ common stock has been assigned a new CUSIP number of 87163U102 in connection with the name change. Outstanding stock certificates are not affected by the name change and will not need to be exchanged.

Synthetic Biologics is developing, or has partnered the development of, product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis.

MORE NEWS: UAW Workers For Stellantis Expected to Get $8,000 in Bonuses

More at www.syntheticbiologics.com.